CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]
A number of firms have modified their ratings and price targets on shares of CTI BioPharma (NASDAQ: CTIC) recently: 5/15/2023 – CTI BioPharma was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. 5/11/2023 – CTI BioPharma was downgraded by analysts at JMP Securities from an “outperform” rating to a […]